| Integrated time-lapse and single-cell transcription studies highlight the variable and dynamic nature of human hematopoietic cell fate commitment A Moussy, J Cosette, R Parmentier, C da Silva, G Corre, A Richard, ... PLoS biology 15 (7), e2001867, 2017 | 58 | 2017 |
| Genome editing of expanded CTG repeats within the human DMPK gene reduces nuclear RNA foci in the muscle of DM1 mice ML Scrudato, K Poulard, C Sourd, S Tomé, AF Klein, G Corre, A Huguet, ... Molecular Therapy 27 (8), 1372-1388, 2019 | 52 | 2019 |
| Preclinical development of a lentiviral vector for gene therapy of X-linked severe combined immunodeficiency V Poletti, S Charrier, G Corre, B Gjata, A Vignaud, F Zhang, M Rothe, ... Molecular Therapy-Methods & Clinical Development 9, 257-269, 2018 | 48 | 2018 |
| Stochastic fluctuations and distributed control of gene expression impact cellular memory G Corre, D Stockholm, O Arnaud, G Kaneko, J Viñuelas, Y Yamagata, ... PLoS One 9 (12), e115574, 2014 | 41 | 2014 |
| Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins G Pavani, M Laurent, A Fabiano, E Cantelli, A Sakkal, G Corre, PJ Lenting, ... Nature communications 11 (1), 3778, 2020 | 38 | 2020 |
| Bistable cell fate specification as a result of stochastic fluctuations and collective spatial cell behaviour D Stockholm, F Edom-Vovard, S Coutant, P Sanatine, Y Yamagata, ... PLoS One 5 (12), e14441, 2010 | 32 | 2010 |
| Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy F Amor, A Vu Hong, G Corre, M Sanson, L Suel, S Blaie, L Servais, T Voit, ... Journal of cachexia, sarcopenia and muscle 12 (3), 677-693, 2021 | 29 | 2021 |
| Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients E Masat, P Laforêt, M De Antonio, G Corre, B Perniconi, N Taouagh, ... Scientific reports 6 (1), 36182, 2016 | 29 | 2016 |
| Lentiviral Transduction of CD34+ Cells Induces Genome-Wide Epigenetic Modifications Y Yamagata, V Parietti, D Stockholm, G Corre, C Poinsignon, N Touleimat, ... PloS one 7 (11), e48943, 2012 | 29 | 2012 |
| An AAV-SGCG dose-response study in a γ-sarcoglycanopathy mouse model in the context of mechanical stress D Israeli, J Cosette, G Corre, F Amor, J Poupiot, D Stockholm, M Montus, ... Molecular Therapy Methods & Clinical Development 13, 494-502, 2019 | 28 | 2019 |
| Hypoxic culture conditions enhance the generation of regulatory T cells TMA Neildez‐Nguyen, J Bigot, S Da Rocha, G Corre, F Boisgerault, ... Immunology 144 (3), 431-443, 2015 | 26 | 2015 |
| Pre-clinical development of a lentiviral vector expressing the anti-sickling βAS3 globin for gene therapy for sickle cell disease V Poletti, F Urbinati, S Charrier, G Corre, RP Hollis, BC Fernandez, ... Molecular Therapy-Methods & Clinical Development 11, 167-179, 2018 | 23 | 2018 |
| miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy M Sanson, A Vu Hong, E Massourides, N Bourg, L Suel, F Amor, G Corre, ... Scientific reports 10 (1), 9139, 2020 | 22 | 2020 |
| Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A W Lostal, C Roudaut, M Faivre, K Charton, L Suel, N Bourg, H Best, ... Science translational medicine 11 (520), eaat6072, 2019 | 21 | 2019 |
| Systemic epigenetic response to recombinant lentiviral vectors independent of proviral integration T Aranyi, D Stockholm, R Yao, C Poinsignon, T Wiart, G Corre, ... Epigenetics & Chromatin 9, 1-10, 2016 | 16 | 2016 |
| Global genome decompaction leads to stochastic activation of gene expression as a first step toward fate commitment in human hematopoietic cells R Parmentier, L Racine, A Moussy, S Chantalat, R Sudharshan, ... PLoS Biology 20 (10), e3001849, 2022 | 12 | 2022 |
| Serotype-specific binding properties and nanoparticle characteristics contribute to the immunogenicity of rAAV1 vectors M Ferrand, S Da Rocha, G Corre, A Galy, F Boisgerault Molecular Therapy 23 (6), 1022-1033, 2015 | 9 | 2015 |
| Temporary reduction of membrane CD4 with the antioxidant MnTBAP is sufficient to prevent immune responses induced by gene transfer S Da Rocha, J Bigot, F Onodi, J Cosette, G Corre, J Poupiot, D Fenard, ... Molecular Therapy-Methods & Clinical Development 14, 285-299, 2019 | 8 | 2019 |
| Constraints on human CD34+ cell fate due to lentiviral vectors can be relieved by valproic acid A Moussy, N Papili Gao, G Corre, V Poletti, S Majdoul, D Fenard, ... Human gene therapy 30 (8), 1023-1034, 2019 | 8 | 2019 |
| Lentiviral standards to determine the sensitivity of assays that quantify lentiviral vector copy numbers and genomic insertion sites in cells G Corre, A Seye, S Frin, M Ferrand, K Winkler, C Luc, F Dorange, ... Gene Therapy 29 (9), 536-543, 2022 | 7 | 2022 |
